CDKN2A/CDKN2B DNA copy number aberrations have been reported to be highly prevalent in MPNST, myxofibrosarcoma, and undifferentiated pleomorphic sarcomas and were associated with a poor prognosis in soft tissue sarcomas. This evidence concerns the gene CDKN2A and soft tissue sarcoma.